Danaher Corporation is a leading company specializing in professional, medical, industrial, and commercial products. As of now, the DHR stock demonstrates growth potential with positive sector dynamics. However, investors should closely evaluate market conditions and competitive positioning.
The fundamentals of Danaher Corporation indicate a solid performance with promising prospects. The ratings reflect strong financial health and potential for growth in various segments.
Category | Score | Visualization |
---|---|---|
Discounted Cash Flow | 4 | |
Return on Equity | 3 | |
Return on Assets | 4 | |
Debt to Equity | 2 | |
Price to Earnings | 1 | |
Price to Book | 3 |
Historical data reveal trends that could help prospective investors make informed decisions. Recent metrics show maintained stability in performance-oriented fundamentals.
Date | Overall Score | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-07-08 | 3 | 4 | 3 | 4 | 2 | 1 | 3 |
Previous | 0 | 4 | 3 | 4 | 2 | 1 | 3 |
Price targets reflect a general optimism surrounding Danaher, with varied predictions indicating potential price movement.
High | Low | Median | Consensus |
---|---|---|---|
$260 | $231 | $240 | $242.75 |
Analysts' recommendations show a strong buy sentiment, indicating confidence in Danaher's market position.
Recommendation | Count | Visualization |
---|---|---|
Strong Buy | 1 | |
Buy | 29 | |
Hold | 9 | |
Sell | 1 | |
Strong Sell | 0 |
Danaher Corporation holds a steady position within its industry, leveraging its diverse product offerings and strategic segments. The fundamentals and historical data suggest stable growth potential despite minor challenges. Analysts imbue confidence with a dominant buy sentiment, aligning with favorable price target projections. Investors should remain attentive to market conditions and sector-specific dynamics to capitalize on potential gains. Overall, DHR presents a balanced opportunity with calculated risks.